Immune Response News and Research

RSS

Study finds prior infection boosts antibody responses after a single COVID-19 vaccination

In a recent study, researchers evaluated the antibody response in previously infected individuals after a single dose of several COVID-19 vaccines.

14 Dec 2021

Correlation between idiopathic pulmonary fibrosis and COVID-19

A new study investigates the genetic overlap between COVID-19 and idiopathic pulmonary fibrosis to identify possible shared biological mechanisms.

14 Dec 2021

11 exceptional recipients of the 2021 Lupus Innovation Award announced

The Lupus Research Alliance proudly announced today 11 research grant recipients in the U.S. and around the world of the 2021 Lupus Innovation Award which will fund wide ranging areas from probing the development and progression of lupus to pointing to potential personalized therapies.

14 Dec 2021

Duke Human Vaccine Institute secures federal contract for advancing investigational vaccines

The National Institute of Allergy and Infectious Diseases awarded researchers at the Duke Human Vaccine Institute a contract that enables it to compete for projects advancing investigational vaccines to production for use in early clinical trials.

14 Dec 2021

SARS-CoV-2 patients exhibit high specialized pro-resolving molecule serum levels

In a new study, researchers compared the serum levels of bioactive lipids in a cohort of 50 in-patients who had confirmed symptomatic SARS-CoV-2 infection with that of a control group.

14 Dec 2021

Vaccinated seropositive individuals are able to induce high anti-spike SIgA responses

Results of a new study show that the induction of anti-SARSCoV-2 spike saliva SIgA antibodies after vaccination is independent of the gender or type of vaccine received.

14 Dec 2021

Changes in trajectory of long COVID symptoms before vaccination

A new preprint describes the results of a study examining this aspect of the disease.

14 Dec 2021

Assay for the identification of SARS-CoV-2 Spike reactive T and B cells

An interesting new paper presents a new assay for B and T lymphocytes in individuals infected with SARS-CoV-2.

14 Dec 2021

Evaluating the exclusion of unvaccinated people in the prevention of SARS-CoV-2 transmission

New study results suggest that the numbers needed to exclude model and baseline infection risk could be key indicators of the drawbacks and benefits of vaccine mandates and vaccine passports.

14 Dec 2021

Risk of SARS-CoV-2 reinfection in children compared to adults

The current study aimed to explore the rate and risk of SARS-CoV-2 reinfections in children.

14 Dec 2021

New mRNA vaccine platform provides stronger protection against SARS-CoV-2 delta variant

A group of researchers from various institutions developed a nucleoside-modified mRNA vaccine that encodes the SARS-CoV-2 N protein (mRNA-N) and is formulated in lipid nanoparticles for this investigation (LNP).

14 Dec 2021

Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV

A highly anticipated clinical trial in eight sub-Saharan countries is the first to specifically evaluate the efficacy of a COVID-19 vaccine in people living with HIV, including those with poorly controlled infections.

13 Dec 2021

Determination of the effectiveness of COVID-19 vaccination using T cell receptor repertoire

A new study published on the bioRxiv preprint server has hypothesized that T cell receptors (TCR) repertoire can measure the response to vaccines, as it would identify the TCR of clones that respond to the vaccination.

13 Dec 2021

Iota-carrageenan inhibits replication of SARS-CoV-2 VOCs

Scientists have recently reported the efficacy of carrageenan against both the SARS-CoV-2 original strain as well as the Alpha, Beta, Gamma, and Delta VOCs.

13 Dec 2021

Impact of tumor environments on susceptibility and course of disease in those infected with SARS-CoV-2

A review assessed the impact of "hot" vs. "cold" immune/tumor environments (and associated therapies) on susceptibility and disease course in subjects with these two types of tumors and infected with SARS-CoV-2 to decipher the mechanisms that drive these adverse outcomes in COVID-19 infected cancer patients.

13 Dec 2021

Immune Response News and Research

Study finds prior infection boosts antibody responses after a single COVID-19 vaccination

Correlation between idiopathic pulmonary fibrosis and COVID-19

11 exceptional recipients of the 2021 Lupus Innovation Award announced

Duke Human Vaccine Institute secures federal contract for advancing investigational vaccines

SARS-CoV-2 patients exhibit high specialized pro-resolving molecule serum levels

Vaccinated seropositive individuals are able to induce high anti-spike SIgA responses

Changes in trajectory of long COVID symptoms before vaccination

Assay for the identification of SARS-CoV-2 Spike reactive T and B cells

Evaluating the exclusion of unvaccinated people in the prevention of SARS-CoV-2 transmission

Risk of SARS-CoV-2 reinfection in children compared to adults

New mRNA vaccine platform provides stronger protection against SARS-CoV-2 delta variant

Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV

Determination of the effectiveness of COVID-19 vaccination using T cell receptor repertoire

Iota-carrageenan inhibits replication of SARS-CoV-2 VOCs

Impact of tumor environments on susceptibility and course of disease in those infected with SARS-CoV-2

Bioinformatics pipeline can be used to quickly identify SARS-CoV-2 therapeutics

Study suggests pre-existing human common cold coronavirus antibodies hinder SARS-CoV-2 immunity

Researchers develop a universal SARS-CoV-2 neutralizing antibody

MV130 immunotherapy boosts natural and vaccine-induced SARS-CoV-2 immunity in mice

Cellular properties of SARS-CoV-2 spike protein RBD in virus-infected African green monkey kidney epithelial cells

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News